An instrument assessing satisfaction with iron chelation therapy: Psychometric testing from an open-label clinical trial

Advances in Therapy

Volumn 27, Issue 8, 2010, Pages 533-546

  Rofail, Diana ^a   Viala, Muriel ^a   Gater, Adam ^a   Abetz Webb, Linda ^a   Baladi, Jean Francois ^b   Cappellini, Maria Domenica ^c  

^a MAPI VALUES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

instrument; iron overload; oral iron chelation therapy; satisfaction

Indexed keywords

DEFERASIROX; FERRITIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHELATION THERAPY; CHILD; CLINICAL ASSESSMENT TOOL; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT VALIDITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; IRON CHELATION; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SATISFACTION WITH IRON CHELATION THERAPY QUESTIONNAIRE; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36;

ADULT; BLOOD TRANSFUSION; FERRITINS; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOMETRICS; QUESTIONNAIRES; REFERENCE STANDARDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956226703     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0049-y     Document Type: Article

References (37)

1. N.F. Olivieri G.M. Brittenham 1997 Iron-chelating therapy and the treatment of thalassemia Blood 89 739 761 9028304
2. Information Center for Sickle Cell and Thalassemic Disorders. Effects of iron overload: hemochromatosis, tranfusional iron overload. 1999. Available at: http://sickle.bwh.harvard.edu/hemochromatosis.html. Accessed June 26, 2010.
3. A. Inati 2009 Recent advances in improving the management of sickle cell disease Blood Rev 23 Suppl1 S9 13 10.1016/S0268-960X(09)70004-9 20116638
4. A. Ismail M. Campbell H. Ibrahim G. Jones 2006 Health related quality of life in Malaysian children with thalassaemia Health Qual Life Outcomes 4 39 10.1186/1477-7525-4-39 16813662
5. V. Vidler 1998 Compliance with iron chelation therapy in beta thalassaemia Paediatr Nurs 10 17 18 10095669
6. K.A. Payne M.P. Desrosiers J.J. Caro 2007 Clinical and economic burden of infused iron chelation therapy (ICT) in the United States Transfusion 47 1820 1829 10.1111/j.1537-2995.2007.01398.x 17880607
7. K.A. Payne D. Rofail J.F. Baladi 2008 Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload Adv Ther 25 725 742 10.1007/s12325-008-0085-z 18704280
8. L. Scalone L.G. Mantovani M. Krol 2008 Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study Curr Med Res Opin 24 1905 1917 10.1185/03007990802160834 18507891
9. Shumaker SA, Berzon RA. The international assessment of HRQL. Theory, translations, measurement and analysis. Oxford, UK: Rapid Communications; 1995.
10. P. Rebulla 1990 Transfusion reac tions in thalassemia. A survey from the Cooleycare programme. The Cooleycare Cooperative Group Haematologica 75 Suppl5 122 127 2086372
11. P.J. Giardina R.W. Grady 2001 Chelation therapy in betathalassemia: an optimistic update Semin Hematol 38 360 366 10.1016/S0037-1963(01)90030-7 11605171
12. V. Alymara D. Bourantas A. Chaidos 2004 Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone Hematol J 5 475 479 10.1038/sj.thj.6200550 15570288
13. Cappellini MD. Removing the burden - iron overload and deferasirox (ICL670). US Oncological Disease 2006;67-68. Available at: www.touchcardiology. com/files/article-pdfs/onco-6726. Accessed June 16, 2010.
14. E. Vichinsky Z. Pakbaz O. Onyekwere 2008 Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial Acta Haematol 119 133 141 10.1159/000125550 18408362
15. L. Abetz J.F. Baladi P. Jones D. Rofail 2006 The impact of iron overload and its treatment on quality of life: results from a literature review Health Qual Life Outcomes 4 73 10.1186/1477-7525-4-73 17007645
16. D. Rofail L. Abetz M. Viala C. Gait J.F. Baladi K. Payne 2009 Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed questionnaire Value Health 12 109 117 10.1111/j.1524-4733.2008.00390.x 18637142
17. J.E. Ware C.D. Sherbourne 1992 The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Medical Care 30 473 483 10.1097/00005650-199206000-00002 1593914
18. R.G. Guy M. Norvell 1977 The neutral point on a Likert Scale J Psychol 95 199 204
19. J.J. Ray 1990 Acquiescence and problems with forced-choice scales J Social Psychol 130 397 399
20. Ware JE, Kosinski M, Dewey JE. How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric Inc.; 2000.
21. L.J. Cronbach 1951 Coefficient alpha and the internal structure of tests Psychometrika 16 297 334 10.1007/BF02310555
22. Nunnally JC. Psychometric Theory. 2nd edition. New York, USA: McGraw Hill; 1978.
23. D.T. Campbell D.W. Fiske 1959 Convergent and discriminant validation by the multitrait-multimethod matrix Psychol Bull 56 81 105 10.1037/h0046016 13634291
24. D.L. Rock W.E. Fordyce 1982 Item convergent validity: a new method of analysis for frequency of continuously scaled data J Exp Educ 51 38 41
25. Kline P. Handbook of psychological testing. 2nd edition. London, UK: Routledge; 1999.
26. E.F. Juniper G.H. Guyatt A. Willan L.E. Griffith 1994 Determining the minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 81 87 10.1016/0895-4356(94)90036-1 8283197
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. New York, USA: Erlbaum; 1988.
28. G.M. Addison M.R. Beamish C.N. Hales M. Hodgkins A. Jacobs P. Llewellin 1972 An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload J Clin Pathol 25 326 329 10.1136/jcp.25.4.326 5063755
29. A. Jacobs F. Miller M. Worwood M.R. Beamish C.A. Wardrop 1972 Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload Br Med J 4 206 208 10.1136/bmj.4.5834.206 5082548
30. G.H. Guyatt D. Osoba A.W. Wu K.W. Wyrwich G.R. Norman 2002 Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 371 383 10.4065/77.4.371 11936935
31. R.D. Hays J.M. Woolley 2000 The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it Pharmacoeconomics 18 419 423 10.2165/00019053-200018050-00001 11151395
32. J.A. Hall M.C. Dornan 1990 Patient sociodemographic characteristics as predictors of satisfaction with medical care: a meta-analysis Soc Sci Med 30 811 818 10.1016/0277-9536(90)90205-7 2138357
33. Y. Lee J.D. Kasper 1999 Age differences in ratings of medical care among older adults living in the community Aging 11 132 135
34. J.E. Byles P.F. Hanrahan M.J. Schofield 1997 "It would be good to know you're not alone": the health care needs of women with menstrual symptoms Fam Prac 14 249 254 10.1093/fampra/14.3.249
35. R. Hays T. Hayashi 1990 Beyond internal consistency reliability: rationale and user's guide for Multi-trait Analysis Program on the microcomputer Behav Res Meth Instrum Comput 22 167 175
36. Cattell RB. Personality and Mood by Questionnaire. San Francisco, CA: Jossey-Bass; 1973.
37. J. Sitzia N. Wood 1997 Patient satisfaction: a review of issues and concepts Soc Sci Med 45 1829 1843 10.1016/S0277-9536(97)00128-7 9447632